New Key Statistics Module, Z-Score and F-Score
NAS:XENE Key Ratios
Market Cap $ M | 3,202.67 |
Enterprise Value $ M | 2,612.47 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.45 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.72 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -15.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.20 |
EV-to-EBITDA | -12.41 |
PEG | -- |
Shares Outstanding M | 75.46 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 23.65 |
Current Ratio | 23.65 |
ROA % (ttm) | -24.03 |
ROE % (ttm) | -25.20 |
ROIC % (ttm) | -109.85 |
Dividend Yield % | -- |
Altman Z-Score | -- |
XENE Number of Guru Trades
XENE Volume of Guru Trades
Gurus Latest Trades with NAS:XENE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XENE is held by these investors
Total 3
Xenon Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:XENE
Total 0- 1